Where NXP001 needs to be27 Apr 2019 17:40
Hi .
I have wondered about 80% and thought that would be a big hurdle .
Silly me of course all NFX will be required to do is prove up bio-equivalence, of 80% of the leading drug on the market which might only be in its self say 5% bio-equivalence so 80% of that 5% we be the tipping point.
I suggest that Dan would not be as confident if this was other wise.
I myself watching this unfold am ever confident that the results will be favorable.
I am sure that when these results come out, Dan and his formidable team will be every busy.